07th Jan 2016- Mumbai, India: Bharatbook.com announces a report on “Research Report on In Vitro Diagnostics Technologies and Global Markets” This report provides a complete review and analysis of the current trends in the IVD markets, along with industry growth drivers and restraints.
The global market for in vitro diagnostics (IVD) products was totaled at $57.3 billion in 2014. It is expected to grow from $60.3 billion in 2015 to $81.1 billion by 2020 at a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020.
This report provides:
-An overview of the global markets and related technologies for in vitro diagnostics
-Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020
-Detailed coverage of application areas, end users, and factors influencing and inhibiting demand for IVD
Information about IVD products including reagents, instruments, and data management softwares and services
-A look at how the rise in the number of diseases like respiratory infections, hospital acquired infections (HAI), and sexually transmitted diseases are creating a constant need for infectious disease testing both in hospitals and laboratories
-Segmentation into immunochemistry, clinical chemistry, SMBG, POC, MDx, hematology, microbiology, hemostasis and tissue diagnostics
-Application analysis: Diabetes, infectious, oncology, cardiology, neurology and others.
-Profiles of major players in the industry
INTRODUCTIONSTUDY GOALS AND OBJECTIVES
This report offers a comprehensive analysis of the global in-vitro diagnostic market, along with an in-depth study of the various IVD segments (clinical chemistry, immunoassays, point-of-care diagnostics, molecular diagnostics, hematology, microbiology and tissue diagnostics); products (instruments, reagents and accessory products); end-user groups (central labs, critical care, OTC/self-testing and academia); and the regional markets of North America, Europe, Asia and LAAM (Latin America/Africa/Middle East).
REASONS FOR DOING THIS STUDY
In vitro diagnostic tests performed on biological samples, such as blood, urine, saliva, spinal fluid and DNA, are a key component of health care delivery. The information provided by IVD tests enable medical care providers to manage several diseases through timely prevention, diagnosis and decision making, and by administering patient-specific treatment modalities.
Today, more than 4,000 different diagnostic tests have become available, and as more IVD tests become compatible with POC environments, health care providers should take advantage of the benefits of these evolving IVDs for effective treatment of life-threatening illnesses through optimization of healthcare delivery. IVDs have already tremendously impacted cancer diagnosis and treatment globally by gaining deeper insights into genetic pathways of the disease enabled by human genome sequencing. As a result, identifying faulty genes, personalized risk predictions and tailored therapies have now become possible.
CONTRIBUTION OF THE STUDY AND FOR WHOM
The intended audience includes all the stakeholders of the IVD market: diagnostic test manufacturing companies, disposable vendors, reagent suppliers, start-ups, technology and business incubators, venture capital firms, hospitals, diagnostic labs, physician offices and groups, university research groups and other involved participants. With its broad scope and in-depth analyses, this study is a valuable resource to anyone involved with or interested in the development and promotion of IVD technologies.
Since this study provides business and technical information of a timely nature, it will prove valuable to a variety of readers, including industry executives, managers and planners, purchasers, industry analysts and investors. The projections, forecasts and trend analyses found in this report provide readers with the necessary data and information for careful decision-making and products that will best meet the needs of the IVD segment.
SCOPE OF REPORT
The scope of this study is global. BCC Research analyzes each market and its applications, regulatory environment, technologies involved, market projections and market shares. The emerging markets discussed include countries such as India, China, Korea, Taiwan, Africa, Australia, Brazil and Russia, among others. The report also examines the IVD market drivers as well as restraints and challenges affecting its growth. Further, the report also highlights the emerging products and technologies and associated start-ups that are likely to accelerate the growth of the IVD industry through their best practices in the research and development of IVDs. Excluded from this study are diagnostic testing such as imaging, veterinary diagnostics and their associated products.
This study will provide information on these areas:
-Structure and current market size of the IVD market as outlined with forecasts through 2020.
-Impact of chronic diseases, growing and aging populations.
-Current technology and product suppliers and key innovations.
-A look at the IVD industry and trends affecting the market.
-Markets by each segment (immunochemistry, molecular diagnostics, POC tests, clinical microbiology, hematology and tissue diagnostics) provide a global overview showing market data for the U.S., Europe, Asia and LAAM regions.
-Emerging opportunities and potential investment opportunity areas for IVD.
-Technology patent trends relating to IVD.
-Profiles for more than 20 companies in the industry with significant contributions and market shares.
Information for this report was derived from a variety of primary and secondary research sources, including industry analysts, annual reports and Securities and Exchange Commission (SEC) reports, the United Network for Organ Sharing (UNOS), the Organ Procurement and Transplantation Network (OPTN), the Scientific Registry of Transplant Recipients (SRTR), the Center for Medicare and Medicaid Services (CMS), the National Institutes of Health (NIH), the Centers for Disease Control (CDC), other government agencies and journal articles. Secondary sources include literature searches, product literature and press releases. When precise information was not available, a consensus was made using reasonable assumptions and estimates based on historical data. Data were collected through interviews and correspondence with IVD industry experts. Projections were based on estimates and information based on historical revenue trends in subsegments, validations through primary research, mergers and acquisitions, and market trends.
For more information kindly visit: https://www.bharatbook.com/diagnostics-market-research-reports-193573/in-vitro-diagnostics-technologies-global.html
About Bharat Book Bureau :
Bharat Book Bureau is the leading market research information provider for market research reports, company profiles, industry analysis, country reports, business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.
In case the reports don’t match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.
Contact us at :
Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Follow us on Twitter: https://twitter.com/researchbook
Follow us on LinkedIn : http://www.linkedin.com/company/bharat-book-bureau
Our Blog : https://www.bharatbook.com/blog/
Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.